General Information of Drug (ID: DMF21XQ)

Drug Name
NGM120 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMF21XQ

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
GDNF family receptor alpha-like (GFRAL) TTE61UB GFRAL_HUMAN Antagonist [2]

References

1 ClinicalTrials.gov (NCT04068896) Study of NGM120 in Subjects With Advanced Solid Tumors and Pancreatic Cancer Using Combination Therapy. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of NGM Biopharmaceuticals.